Shandong Xinhua Pharmaceutical Company Limited Cash Flow Quality Index
Shandong Xinhua Pharmaceutical Company Limited cash flow quality index. Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Cash Flow Quality Index of 0.46x as of September 2023. Operating cash flow of €56.11 Million is below net income of €122.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore XIN operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Cash flow quality index of Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025. Historical Cash Flow Quality Index for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. See XIN equity financing ratio to measure how much of total assets are equity-financed.
Shandong Xinhua Pharmaceutical Company Limited Cash Flow Quality Index by Year (2013–2025)
Shandong Xinhua Pharmaceutical Company Limited cash flow quality index by year from 2013 to 2025. Year-by-year earnings quality comparison for Shandong Xinhua Pharmaceutical Company Limited. For the full cash flow conversion analysis, see XIN operating cash flow.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.84x | €533.73 Million | €289.89 Million | ▲ +135.4% |
| 2024 | 0.78x | €367.61 Million | €470.02 Million | ▲ +46.4% |
| 2023 | 0.53x | €265.28 Million | €496.51 Million | ▼ -71.0% |
| 2022 | 1.84x | €758.24 Million | €411.19 Million | ▲ +148.0% |
| 2021 | 0.74x | €259.12 Million | €348.55 Million | ▼ -42.5% |
| 2020 | 1.29x | €420.19 Million | €324.86 Million | ▲ +11.4% |
| 2019 | 1.16x | €348.27 Million | €299.97 Million | ▼ -8.5% |
| 2018 | 1.27x | €323.91 Million | €255.31 Million | ▼ -31.8% |
| 2017 | 1.86x | €389.97 Million | €209.59 Million | ▼ -48.2% |
| 2016 | 3.59x | €439.35 Million | €122.27 Million | ▼ -14.4% |
| 2015 | 4.20x | €348.64 Million | €83.06 Million | ▼ -38.5% |
| 2014 | 6.83x | €346.34 Million | €50.73 Million | ▲ +154.6% |
| 2013 | 2.68x | €104.99 Million | €39.15 Million | — |